TSH ≥30 mU/lmU/l may not be necessary for successful 131I remnant ablation after total thyroidectomy in patients with differentiated thyroid cancer

被引：0
|
作者：
Shen, Chentian [1 ]
Ju, Nianting [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Sch Med, Shanghai, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P114
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma
    Lee, Hyo Jin
    Rha, So Young
    Jo, Young Suk
    Kim, Seong Min
    Ku, Bon Jeong
    Shong, Minho
    Kim, Young Kun
    Ro, Heung Kyu
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (01): : 63 - 68
  • [42] Recombinant TSH or thyroid hormone withdrawal?: A comparison of I-131 remnant ablation rates in thyroid cancer patients
    Luster, M
    Ladenson, P
    Pacini, F
    Schlumberger, M
    Driedger, A
    Kloos, R
    Sherman, S
    Corone, C
    Haugen, B
    Lassmann, M
    Hänscheid, H
    Reiners, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S290 - S291
  • [43] Postablative 131I SPECT/CT Is Much More Sensitive Than Cervical Ultrasonography for the Detection of Thyroid Remnants in Patients After Total Thyroidectomy for Differentiated Thyroid Cancer
    Bulzacka, Iwona
    Makarewicz, Jacek
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (12) : 948 - 953
  • [44] Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: A distillation and comparison of guidelines from seven organizations
    Guan, Haixia
    Van Nostrand, Douglas
    Li, Yaming
    Orquiza, Michael
    Teng, Weiping
    Khorjekar, Gauri
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54
  • [45] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Jin, Pingyan
    Feng, Huijuan
    Ouyang, Wei
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Sun, Yungang
    Xian, Jialang
    Huang, Liuhua
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2018, 57 (02) : 169 - 177
  • [46] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Pingyan Jin
    Huijuan Feng
    Wei Ouyang
    Juqing Wu
    Pan Chen
    Jing Wang
    Yungang Sun
    Jialang Xian
    Liuhua Huang
    Radiation and Environmental Biophysics, 2018, 57 : 169 - 177
  • [47] No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
    Frederik Anton Verburg
    Marcel P. M. Stokkel
    Christian Düren
    Robbert B. T. Verkooijen
    Uwe Mäder
    Johannes W. van Isselt
    Robert J. Marlowe
    Johannes W. Smit
    Christoph Reiners
    Markus Luster
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 276 - 283
  • [48] No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
    Verburg, Frederik Anton
    Stokkel, Marcel P. M.
    Dueren, Christian
    Verkooijen, Robbert B. T.
    Maeder, Uwe
    van Isselt, Johannes W.
    Marlowe, Robert J.
    Smit, Johannes W.
    Reiners, Christoph
    Luster, Markus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (02) : 276 - 283
  • [49] Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma
    Kim, TY
    Kim, WB
    Kim, ES
    Ryu, JS
    Yeo, JS
    Kim, SC
    Hong, SJ
    Shong, YK
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03): : 1440 - 1445
  • [50] The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I
    Verburg, F. A.
    Verkooijen, R. B. T.
    Stokkel, M. P. M.
    van Isselt, J. W.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2009, 48 (04): : 138 - 142
12345